| scholarly article | Q13442814 |
| P50 | author | Lawrence Corey | Q6503944 |
| Meei-Li Huang | Q61713476 | ||
| Harvey M. Friedman | Q89912954 | ||
| David M Koelle | Q40734874 | ||
| P2093 | author name string | Sita Awasthi | |
| Gregory G Mahairas | |||
| Christine Posavad | |||
| Carolyn E Shaw | |||
| P2860 | cites work | Risk Factors for the Sexual Transmission of Genital Herpes | Q22305344 |
| Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections | Q22305966 | ||
| An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection | Q24646809 | ||
| Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia | Q24685440 | ||
| Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding | Q28236882 | ||
| Virologic characteristics of subclinical and symptomatic genital herpes infections | Q28295661 | ||
| Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes | Q30496837 | ||
| CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. | Q30657379 | ||
| Expression cloning for the discovery of viral antigens and epitopes recognized by T cells | Q30923248 | ||
| CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins | Q30957753 | ||
| Alternate serotype adenovector provides long-term therapeutic gene expression in the eye. | Q33397385 | ||
| Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. | Q33826410 | ||
| Herpes Simplex Virus-Specific Memory CD8+ T Cells Are Selectively Activated and Retained in Latently Infected Sensory Ganglia | Q33854496 | ||
| Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons | Q33881052 | ||
| Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. | Q33963010 | ||
| Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28. | Q34081164 | ||
| Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes | Q34279175 | ||
| Once-daily valacyclovir to reduce the risk of transmission of genital herpes | Q34287411 | ||
| The acquisition of herpes simplex virus during pregnancy | Q34436031 | ||
| Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors | Q34457800 | ||
| Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis | Q34470594 | ||
| Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. | Q34545821 | ||
| Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes | Q34648207 | ||
| Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons | Q43704029 | ||
| Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. | Q43749186 | ||
| The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway | Q44018412 | ||
| Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice | Q44745406 | ||
| Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture | Q45162165 | ||
| A paradigm shift: vaccine-induced antibodies as an immune correlate of protection against herpes simplex virus type 1 genital herpes | Q45167552 | ||
| Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission | Q45391170 | ||
| Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy | Q45609794 | ||
| Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India | Q45723796 | ||
| Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. | Q45729656 | ||
| Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. | Q45732556 | ||
| Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production | Q45742610 | ||
| A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia | Q45747968 | ||
| Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. | Q45752846 | ||
| Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. | Q45754911 | ||
| Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects | Q45796145 | ||
| Genital Herpes in Guinea Pigs: Pathogenesis of the Primary Infection and Description of Recurrent Disease | Q46204086 | ||
| Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes | Q57076537 | ||
| T Cell Immunity to Herpes Simplex Viruses in Seronegative Subjects: Silent Infection or Acquired Immunity? | Q59654818 | ||
| Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures | Q67488109 | ||
| Effects on infants of a first episode of genital herpes during pregnancy | Q69810225 | ||
| Exploring biomolecular recognition using optical biosensors | Q73097721 | ||
| Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes | Q34648449 | ||
| Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus | Q34777218 | ||
| Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection | Q35129667 | ||
| Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa | Q35275146 | ||
| Efficacy results of a trial of a herpes simplex vaccine | Q35780697 | ||
| Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules | Q35841977 | ||
| Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection | Q35853529 | ||
| High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes | Q35872807 | ||
| Vaccine Adjuvants: Putting Innate Immunity to Work | Q36168232 | ||
| Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation | Q36267182 | ||
| A vaccine strategy that protects against genital herpes by establishing local memory T cells | Q36403540 | ||
| CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons | Q36404348 | ||
| Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses | Q36585733 | ||
| Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. | Q36633084 | ||
| Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor | Q36689912 | ||
| An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs | Q36759693 | ||
| A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. | Q36808087 | ||
| C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2. | Q36881431 | ||
| Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41 | Q36976598 | ||
| Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection | Q37060288 | ||
| Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection | Q37174520 | ||
| A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes | Q37253436 | ||
| Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes | Q37380356 | ||
| Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine | Q37439603 | ||
| Correlate of immune protection against HSV-1 genital disease in vaccinated women | Q37604473 | ||
| Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D. | Q38241377 | ||
| Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. | Q38348319 | ||
| Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions | Q39580355 | ||
| Rapid construction of adenoviral vectors by lambda phage genetics | Q39683249 | ||
| Genital herpes simplex virus infections: clinical manifestations, course, and complications | Q40150591 | ||
| Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade | Q41367489 | ||
| Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization | Q41726663 | ||
| Viral kinetics of genital herpes: a molecular probe into host-viral interactions | Q42842388 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| vector-borne disease | Q2083837 | ||
| genital herpes | Q7476596 | ||
| sexual transmission | Q45349134 | ||
| P304 | page(s) | 8497-8509 | |
| P577 | publication date | 2015-06-03 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens | |
| P478 | volume | 89 |
| Q57072187 | A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection |
| Q34501866 | A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs. |
| Q40210971 | A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model |
| Q64114856 | Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials |
| Q30235026 | Genital Herpes: Insights into Sexually Transmitted Infectious Disease |
Search more.